CasLoc logo
All Cases PTAB Litigations UPC Oppositions

CSPC Pharmaceutical Group Limited et al. vs. Ipsen Biopharm Ltd. et al.

Explore the PTAB proceeding IPR2025-00505 filed by CSPC Pharmaceutical Group Limited et al. on 2025-01-17. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2025-00505

Filing Date

2025-01-17

Accorded Filing Date

2025-01-17

Institution Decision Date

2025-08-14

Last Modified Date

2026-09-15

Proceeding Type

IPR

Termination Date

2026-08-13

Trial Status

Final Written Decision

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 15809815
Respondent Patent Number 11344552
Legal Expiration Date
2037-11-10 Active (11.0 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Eliel Bayever et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

2 Total

Proceeding Status

Final Written Decision

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (2)

Final Written Decision 2026-08-13
Final Written Decision: Final Written Decision Determining Some Challenged Claims Unpatentable 35 U.S.C. sec. 318a Granting Petitioners Motion to Seal (Paper 31 37 C.F.R. secs. 42.14, 42.54 Denying Petitioners Motion to Exclude Paper 43 37 C.F.R. sec. 42.64c Denying Patent Owners Motion to Exclude Paper 42 37 C.F.R. sec. 42.64c
37 CFR 42.100, 37 CFR 42.73, 37 CFR 42.5, 35 USC 311
Institution Granted 2025-08-14
Decision Granting Institution of Inter Partes Review
37 CFR 42.100, 35 USC 315, 35 USC 312, 35 USC 314

Address and Attorney/Agent Information

35 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name McNeill PLLC/Ipsen - Ipsen Bioscience, Inc.
Customer Number 153749
Address 245 First Street, 18th Floor, Cambridge, MA, 02142, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
41195 Arie Michelsohn +1 240-792-2692
41551 Lara Kelley +1 703-243-2007
43076 Fernando Salcedo +1 919-620-2000
43796 Rebecca Mcneill +1 617-489-0002
46512 Amy Schoenhard +1 240-802-2716
47057 Rebecca Scarr +1 414-377-3455
48070 Julie Heinrich +1 412-744-3850
50775 Heidi Dare +1 872-270-2996

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 12 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 1 proceeding
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (12): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2025-09-12
IPR2025-01531

Apotex Inc. v. Ipsen Biopharm Ltd. et al.

Asserted Patent
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

200
53

Final Written Decision: Final Written Decision Determining Some Challenged Claims Unpatentable 35 U.S.C. sec. 318a Granting Petitioners Motion to Seal (Paper 31 37 C.F.R. secs. 42.14, 42.54 Denying Petitioners Motion to Exclude Paper 43 37 C.F.R. sec. 42.64c Denying Patent Owners Motion to Exclude Paper 42 37 C.F.R. sec. 42.64c FINAL

2026-08-13 FILING PARTY: BOARD
52

Other: Hearing transcript OTHER

2026-08-12 FILING PARTY: BOARD
51

Petitioner's Supplemental Brief OTHER

2026-05-29 FILING PARTY: PETITIONER
50

Patent Owner's Supplemental Briefing OTHER

2026-05-29 FILING PARTY: PATENT OWNER
49

ORDER 37 C.F.R. ยง 42.5 ORDER

2026-05-21 FILING PARTY: BOARD

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc